GlassScriptPhysician profile
Matthew Ronai
NPI 1235834185
$1,773.54
in general payments reported to CMS, 2019-2025
11 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,086 · 2024: $494 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,133 · Travel and Lodging: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,132.78 |
| Travel and Lodging | $640.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $1,013.94 | 2023-2025 | |
| Arthrex, INC. | $437.80 | 2023 | |
| Ferring Pharmaceuticals INC. | $89.29 | 2024-2025 | Euflexxa |
| Stryker Corporation | $72.86 | 2025 | Iconix, Blueprint Patient Specific Instrumentation |
| Ethicon US, LLC | $32.14 | 2024 | Monocryl, Vistaseal, Stratafix |
| Ossur Americas, INC. | $28.41 | 2024 | Miami J |
| Sanara Medtech INC. | $23.59 | 2023 | Celleraterx |
| Depuy Synthes Sales INC. | $22.74 | 2025 | Inhance |
| Smith+Nephew, INC. | $18.90 | 2023 | Pico 7, Pico 14 |
| Bioventus LLC | $18.43 | 2025 | Xcell |
| Vericel Corporation | $15.44 | 2023 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Ronai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.